Saudi Journal of Medicine and Medical Sciences

ORIGINAL ARTICLE
Year
: 2022  |  Volume : 10  |  Issue : 2  |  Page : 105--110

Non-invasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP) lowers the risk of malignancy in The Bethesda System for Reporting Thyroid Cytopathology Diagnostic Categories


Hatim Al-Maghrabi1, Mohamed Tashkandi3, Waleed Khayyat3, Amer Alghamdi3, Mohammed Alsalmi3, Alhussain Alzahrani3, Hadi Al-Hakami2, Mohammed Alqarni2 
1 Department of Pathology and Laboratory Medicine, Ministry of the National Guard – Health Affairs; College of Medicine, King Saud Bin Abdulaziz University for Health Sciences; King Abdullah International Medical Research Center, Riyadh, Saudi Arabia
2 College of Medicine, King Saud Bin Abdulaziz University for Health Sciences; King Abdullah International Medical Research Center; Department of Otolaryngology-Head and Neck Surgery, Ministry of the National Guard – Health Affairs, Jeddah, Riyadh, Saudi Arabia

Correspondence Address:
Hatim Al-Maghrabi
King Abdullah International Medical Research Center, National Guard Health Affairs, King Saud Bin Abdulaziz University for Health Sciences, Jeddah, Riyadh
Saudi Arabia

Background: The introduction of non-invasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP) has been shown to decrease the risk of malignancy (ROM) in The Bethesda System for Reporting Thyroid Cytopathology. This knowledge may alter the management of patients with thyroid nodules. Objectives: To correlate cytological diagnosis with histological diagnosis for establishing the ROM of all Bethesda system categories after the introduction of NIFTP. Methods: This was a retrospective cohort study. All consecutive fine-needle aspiration cytology (FNAC) specimens collected from January 1, 2013, to December 31, 2017, at King Abdullah Medical City, Jeddah, Saudi Arabia, were assessed, and patients who underwent surgical excision of thyroid nodules were further analyzed. The ROM and overall ROM for each Bethesda category were calculated with and without considering NIFTP as a malignant tumor. Results: Overall, 1066 FNAC specimens were collected, of which 281 had a surgical correlation. Our cases included 18 (6.4%) non-diagnostic (ND), 109 (38.8%) benign, 28 (9.9%) atypia/follicular lesion of undetermined significance (AUS/FLUS), 39 (13.8%) follicular neoplasm or suspicion for follicular neoplasm (FN/SFN), 20 (7.1%) suspicion for malignancy (SM), and 67 (23.8%) malignant (POM) cases. After considering NIFTP diagnosis on resection specimens, the ROM decreased as follows: ND, 38.8% to 27.7% (P = 0.2388); benign, 21.1% to 11.9% (P = 0.0343); AUS/FLUS, 50% to 39.2% (P = 0.2089); FN/SFN, 53.8% to 33.3% (P = 0.0336); SM, 85% to 75% (P = 0.2147); POM, 95.5% to 88% (P = 0.0582). Conclusion: The introduction of NIFTP would significantly decrease the ROM of thyroid FNAC in both benign and FN/SFN categories of the Bethesda system.


How to cite this article:
Al-Maghrabi H, Tashkandi M, Khayyat W, Alghamdi A, Alsalmi M, Alzahrani A, Al-Hakami H, Alqarni M. Non-invasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP) lowers the risk of malignancy in The Bethesda System for Reporting Thyroid Cytopathology Diagnostic Categories.Saudi J Med Med Sci 2022;10:105-110


How to cite this URL:
Al-Maghrabi H, Tashkandi M, Khayyat W, Alghamdi A, Alsalmi M, Alzahrani A, Al-Hakami H, Alqarni M. Non-invasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP) lowers the risk of malignancy in The Bethesda System for Reporting Thyroid Cytopathology Diagnostic Categories. Saudi J Med Med Sci [serial online] 2022 [cited 2022 Jul 5 ];10:105-110
Available from: https://www.sjmms.net/article.asp?issn=1658-631X;year=2022;volume=10;issue=2;spage=105;epage=110;aulast=Al-Maghrabi;type=0